738 related articles for article (PubMed ID: 16874860)
21. Inhibition of hepatitis B virus replication by APOBEC3G.
Turelli P; Mangeat B; Jost S; Vianin S; Trono D
Science; 2004 Mar; 303(5665):1829. PubMed ID: 15031497
[No Abstract] [Full Text] [Related]
22. Effect of interferon alpha on hepatitis B virus replication and gene expression in transiently transfected human hepatoma cells.
Rang A; Günther S; Will H
J Hepatol; 1999 Nov; 31(5):791-9. PubMed ID: 10580575
[TBL] [Abstract][Full Text] [Related]
23. Doubly Spliced RNA of Hepatitis B Virus Suppresses Viral Transcription via TATA-Binding Protein and Induces Stress Granule Assembly.
Tsai KN; Chong CL; Chou YC; Huang CC; Wang YL; Wang SW; Chen ML; Chen CH; Chang C
J Virol; 2015 Nov; 89(22):11406-19. PubMed ID: 26339052
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of multiple gene expression and virus replication of HBV by stable RNA interference in 2.2.15 cells.
Ren X; Luo G; Xie Z; Zhou L; Kong X; Xu A
J Hepatol; 2006 Apr; 44(4):663-70. PubMed ID: 16466826
[TBL] [Abstract][Full Text] [Related]
25. Specific anti-viral effects of RNA interference on replication and expression of hepatitis B virus in mice.
Wu Y; Huang AL; Tang N; Zhang BQ; Lu NF
Chin Med J (Engl); 2005 Aug; 118(16):1351-6. PubMed ID: 16157029
[TBL] [Abstract][Full Text] [Related]
26. Combination therapy of siRNAs mediates greater suppression on hepatitis B virus cccDNA in HepG2.2.15 cell.
Xin XM; Li GQ; Guan XR; Li D; Xu WZ; Jin YY; Gu HX
Hepatogastroenterology; 2008; 55(88):2178-83. PubMed ID: 19260501
[TBL] [Abstract][Full Text] [Related]
27. Hepatitis B virus mRNAs functionally sequester let-7a and enhance hepatocellular carcinoma.
Deng M; Hou J; Hu J; Wang S; Chen M; Chen L; Ju Y; Li C; Meng S
Cancer Lett; 2016 Dec; 383(1):62-72. PubMed ID: 27693636
[TBL] [Abstract][Full Text] [Related]
28. Mucroporin-M1 inhibits hepatitis B virus replication by activating the mitogen-activated protein kinase (MAPK) pathway and down-regulating HNF4α in vitro and in vivo.
Zhao Z; Hong W; Zeng Z; Wu Y; Hu K; Tian X; Li W; Cao Z
J Biol Chem; 2012 Aug; 287(36):30181-90. PubMed ID: 22791717
[TBL] [Abstract][Full Text] [Related]
29. miR-29a promotes hepatitis B virus replication and expression by targeting SMARCE1 in hepatoma carcinoma.
Wu HJ; Zhuo Y; Zhou YC; Wang XW; Wang YP; Si CY; Wang XH
World J Gastroenterol; 2017 Jul; 23(25):4569-4578. PubMed ID: 28740345
[TBL] [Abstract][Full Text] [Related]
30. Hepatitis B virus DNA is subject to extensive editing by the human deaminase APOBEC3C.
Baumert TF; Rösler C; Malim MH; von Weizsäcker F
Hepatology; 2007 Sep; 46(3):682-9. PubMed ID: 17625792
[TBL] [Abstract][Full Text] [Related]
31. miR-200c targets nuclear factor IA to suppress HBV replication and gene expression via repressing HBV Enhancer I activity.
Tian H; He Z
Biomed Pharmacother; 2018 Mar; 99():774-780. PubMed ID: 29710475
[TBL] [Abstract][Full Text] [Related]
32. Preventive effects of a major component of green tea, epigallocathechin-3-gallate, on hepatitis-B virus DNA replication.
Karamese M; Aydogdu S; Karamese SA; Altoparlak U; Gundogdu C
Asian Pac J Cancer Prev; 2015; 16(10):4199-202. PubMed ID: 26028072
[TBL] [Abstract][Full Text] [Related]
33. Unedited inhibition of HBV replication by APOBEC3G.
Seppen J
J Hepatol; 2004 Dec; 41(6):1068-9. PubMed ID: 15582148
[No Abstract] [Full Text] [Related]
34. Inhibition of the replication of hepatitis B virus in vitro by oxymatrine.
Lin M; Yang LY; Li WY; Peng YP; Zheng JK
J Int Med Res; 2009; 37(5):1411-9. PubMed ID: 19930845
[TBL] [Abstract][Full Text] [Related]
35. IL-4 suppresses the expression and the replication of hepatitis B virus in the hepatocellular carcinoma cell line Hep3B.
Lin SJ; Shu PY; Chang C; Ng AK; Hu CP
J Immunol; 2003 Nov; 171(9):4708-16. PubMed ID: 14568946
[TBL] [Abstract][Full Text] [Related]
36. Comment on "Inhibition of hepatitis B virus replication by APOBEC3G".
Rösler C; Köck J; Malim MH; Blum HE; von Weizsäcker F
Science; 2004 Sep; 305(5689):1403; author reply 1403. PubMed ID: 15353783
[No Abstract] [Full Text] [Related]
37. Anti-hepatitis B virus activity of lithospermic acid, a polyphenol from Salvia miltiorrhiza, in vitro and in vivo by autophagy regulation.
Zhu S; Wen H; Wang W; Chen Y; Han F; Cai W
J Ethnopharmacol; 2023 Feb; 302(Pt A):115896. PubMed ID: 36334815
[TBL] [Abstract][Full Text] [Related]
38. [Study on the differences of two mouse models of hepatitis B virus infection by transduction with rAAV8-1. 3HBV].
Wang G; Dong XY; Tian WH; Yu CJ; Zheng G; Gao J; Wang GJ; Wei GC; Zhou YS; Wu XB
Bing Du Xue Bao; 2012 Sep; 28(5):541-7. PubMed ID: 23233931
[TBL] [Abstract][Full Text] [Related]
39. PTD-fused p53 as a potential antiviral agent directly suppresses HBV transcription and expression.
Chu X; Wu B; Fan H; Hou J; Hao J; Hu J; Wang B; Liu G; Li C; Meng S
Antiviral Res; 2016 Mar; 127():41-9. PubMed ID: 26784393
[TBL] [Abstract][Full Text] [Related]
40. Antiviral effect of Curcuma longa Linn extract against hepatitis B virus replication.
Kim HJ; Yoo HS; Kim JC; Park CS; Choi MS; Kim M; Choi H; Min JS; Kim YS; Yoon SW; Ahn JK
J Ethnopharmacol; 2009 Jul; 124(2):189-96. PubMed ID: 19409970
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
